Cannabidiol, from Past to Present: a Review

Abstract

The cannabis plant contains the naturally occurring substance cannabidiol, also known as CBD. As opposed to its more widely known relative, tetrahydrocannabinol (THC), cannabidiol (CBD), does not possess any psychoactive or euphoria-inducing properties, and is widely regarded as harmless and nonaddictive. Due to its alleged medicinal advantages, which are thought to include pain relief, anxiety reduction, epilepsy management and anti-inflammatory characteristics, CBD has attracted a lot of attention in recent years, in both human and veterinary medicine. The different kinds of CBD products available include oils, tinctures, capsules, lotions, and even edibles in the form of cookies and candy. In the field of veterinary medicine, the use of CBD has become more and more prevalent in recent years, and a formulation of treats for dogs and cats containing varying quantities of cannabidiol have been put on the market. Despite growing in popularity, CBD's legal status is still a little hazy in many nations, and more study is required to fully comprehend both its advantages and disadvantages. This article aims to review CBD’s history, mechanisms of action, potential therapeutic roles as well as adverse effects that have been encountered thus far in clinical studies.

Keywords

• cannabidiol
• cbd
• chronic pain
• epilepsy